Lee F. Dove
- Urology top 5%
- Urological Disorders and Treatments 3
- Molecular Biology top 10%
- Renal and related cancers 10
- Genetics top 10%
- Genetic and Kidney Cyst Diseases 2
-
- Renal cell carcinoma treatment 3
-
- Prenatal Screening and Diagnostics 2
-
- Organ Donation and Transplantation 3
- Acute Lymphoblastic Leukemia research 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Alan O. PerantoniIrina KaravanovaMark LewandoskiCharmaine RichmanCatherine P. WilsonFlorence NaillatOlga TimofeevaSeppo Vainio
- Cited by
- UrologyMolecular BiologyGenetics
- Partner nations
- United StatesFinlandThailand
In The Last Decade
Lee F. Dove
18 papers receiving 843 citations
Peers
Comparison fields: 5 of 72
- Urology 141
- Molecular Biology 742
- Genetics 191
- Pulmonary and Respiratory Medicine 220
- Pediatrics, Perinatology and Child Health 97
Countries citing papers authored by Lee F. Dove
This map shows the geographic impact of Lee F. Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee F. Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee F. Dove more than expected).
Fields of papers citing papers by Lee F. Dove
This network shows the impact of papers produced by Lee F. Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee F. Dove. The network helps show where Lee F. Dove may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lee F. Dove, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 3 | |
| 2 | 2005 | 272 | |
| 3 | 2001 | 126 | |
| 4 | 2000 | 38 | |
| 5 | 2000 | 2 | |
| 6 | 1999 | 7 | |
| 7 | 1997 | 13 | |
| 8 | 1996 | 85 | |
| 9 | 1995 | 137 | |
| 10 | 1994 | 16 | |
| 11 | 1991 | 35 | |
| 12 | Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. | 1989 | 50 |
| 13 | 1985 | 49 | |
| 14 | Selective growth in culture of fetal rat renal collecting duct anlagen. Morphologic and biochemical characterization. | 1985 | 11 |
| 15 | 1978 | 13 | |
| 16 | 1977 | 6 | |
| 17 | 1971 | 1 | |
| 18 | 1969 | 4 | |
| 19 | 1969 | 4 |
About Lee F. Dove
Lee F. Dove is a scholar working on Urology, Pharmacology, Public Health, Environmental and Occupational Health, Molecular Biology and Biochemistry, having authored 19 papers that have together received 872 indexed citations. Recurring topics across this work include Renal and related cancers (10 papers), Renal cell carcinoma treatment (3 papers), Organ Donation and Transplantation (3 papers), Urological Disorders and Treatments (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Genetic and Kidney Cyst Diseases (2 papers), Prenatal Screening and Diagnostics (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Urology (141 citations), Molecular Biology (742 citations), Genetics (191 citations), Pulmonary and Respiratory Medicine (220 citations) and Pediatrics, Perinatology and Child Health (97 citations). Lee F. Dove has collaborated with scholars based in United States, Finland and Thailand. Frequent co-authors include Alan O. Perantoni, Irina Karavanova, Mark Lewandoski, Charmaine Richman, Catherine P. Wilson, Florence Naillat, Olga Timofeeva, Seppo Vainio, Kiyoshi Yoshino and Sergei Y. Plisov. Their work appears in journals such as Development, Gerontology, Reproductive Toxicology, genesis and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.